Genomics

Dataset Information

0

Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [ChIP-Seq]

ABSTRACT: Genome-wide binding/occupancy profiling by high throughput sequencing

ORGANISM(S): Homo sapiens

PROVIDER: GSE129861 | GEO | 2019/11/01

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia
2019-11-01 | GSE129863 | GEO
Transcriptomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [RNA-Seq]
2019-11-01 | GSE129862 | GEO
Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia
| PRJNA533070 | ENA
Unknown Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo.
| S-EPMC6940199 | biostudies-literature
Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [ChIP-Seq]
| PRJNA533061 | ENA
Genomics Chemical Inhibition of Salt-Inducible Kinase as Therapeutic Strategy in Acute Myeloid Leukemia [RNA-Seq]
| PRJNA533192 | ENA
Unknown Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.
| S-EPMC7484148 | biostudies-literature
Unknown Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.
| S-EPMC6558520 | biostudies-literature
Unknown Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.
| S-EPMC3221282 | biostudies-literature
Unknown Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia.
| S-EPMC8238245 | biostudies-literature